Participated · Seed · Aug 2026

Rivo connects to users' existing bank accounts, monitors cash flow in real time, and automatically moves idle balances into higher-yield U.S. Treasury securities through its banking partner, Jiko, returning funds before bills are due. Users do not need to change banks, move money manually, or alter their behavior to receive higher yields. Rivo emphasizes handling edge cases—shifted pay cycles, early bills, shared accounts—drawing on a founding team with experience from Cruise, Amazon, Personal Capital, Mint, Capital One, JPMorgan Chase, Microsoft, and LinkedIn. The company launched out of beta and opened to the public concurrent with its seed financing. Rivo disclosed that treasury investments are provided by Jiko Securities and that securities in accounts are protected by SIPC up to applicable limits. The firm highlighted the scale of idle checking balances in the U.S. as context for its product but did not disclose revenue or user metrics in the announcement.

Participated · Seed · Apr 2026

Ultralight, formerly Vibrant Practice, builds an AI-native vertical SaaS operating system for clinicians running functional, integrative, or longevity-focused practices. Its platform unifies electronic health records, practice management, and patient engagement while natively integrating AI to automate routine administrative tasks and surface deep clinical insights. The company positions its product to enable clinicians to focus on high-touch care by reducing operational overhead. Ultralight plans to use its newly raised seed capital to accelerate development of its AI-powered capabilities and product expansion. The company is headquartered in San Francisco, California. The reporting does not disclose revenue, user counts, or other operating metrics.

Participated · Seed · Mar 2026

Malama Health delivers continuous doula-led maternal care by connecting doula networks, clinical oversight, remote monitoring, and reporting infrastructure within Medicaid markets. The company employs Doula-Care Navigators who provide in-person support, attend births, conduct home visits, and monitor health indicators throughout the postpartum year, escalating clinical risks to medical professionals when needed. Malama incorporates bilingual support, accessible technology and educational content designed at a fifth-grade literacy level, and operates a CDC-certified Diabetes Prevention Program for postpartum risk management. The company reports data from more than 2,500 women showing improvements including reduced NICU admissions, lower C-section rates, and fewer preterm births, and a randomized controlled trial at Tufts found a 40% reduction in postpartum diabetes versus standard care. Malama works with Medicaid managed care plans and health systems including Stanford Health Care, UCSF Health, and UCLA Health, and maintains relationships with more than 600 clinics and hospitals nationwide. The company plans to scale its Doula-Care Navigator workforce and expand into additional states while deepening integrations with health plans and healthcare systems that serve Medicaid populations.

Participated · Seed · Sep 2025

Manas AI builds neuro-symbolic, science-based foundational models that analyze biological data to discover and develop transformative medicines. Co-founded by Dr. Siddhartha Mukherjee, Reid Hoffman, and Ujjwal Singh, the company positions itself as an AI-native drug developer rather than a traditional biotech. Its core product suite consists of proprietary large-scale models designed to accelerate target identification, molecule generation, and pre-clinical validation. The newly raised capital will be directed toward further refining these models and advancing ongoing therapeutic campaigns. Since launch, the startup has secured a total of $50.6 million across two seed financings ($24.6 million in January 2025 and a $26 million extension in September 2025). Investors span top technology and life-science funds, signaling cross-sector confidence in Manas AI’s hybrid AI-biotech approach.

Participated · Series A · Aug 2024

Founded in 2020 by Harvard Business School classmates Tina Keshani, Julia Cole, and Sophia Richter, Seven Starling delivers technology-enabled maternal mental-health care. Its platform combines clinical evaluations, medication management, and both individual and group therapy to treat depression, anxiety, and related conditions tied to parenthood. All services are covered by insurance, helping patients access support without prohibitive out-of-pocket costs. The company plans to use new capital to expand into a dozen additional states by the end of 2026. Seven Starling’s care model targets postpartum, infertility, miscarriage, and loss, aiming to close gaps in traditional maternal health services. To date, the startup has raised $21.8 million across three rounds, giving it resources to scale its virtual operations and provider network.